Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 14.95% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Consumer Staples | 10.7% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
iShares MSCI Chile ETF
ECH
$1.01B
| $477K | ﹤0.01% |
+16,400
| New | +$429K |
|
3227
Hawthorn Bancshares
HWBK
$269M
| $475K | ﹤0.01% |
20,307
-3,551
| -15% | -$84.8K |
|
3228
Oportun Financial
OPRT
$255M
| $475K | ﹤0.01% |
33,100
+11,300
| +52% | +$188K |
|
|
TRHC
3229
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $475K | ﹤0.01% |
+82,435
| New | +$740K |
|
3230
Elicio Therapeutics
ELTX
$73.5M
| $474K | ﹤0.01% |
22,370
+3,260
| +17% | +$73.6K |
|
3231
WisdomTree US LargeCap Dividend Fund
DLN
$6.26B
| $473K | ﹤0.01% |
7,200
-11,200
| -61% | -$725K |
|
3232
Birks Group
BGI
$9.46M
| $471K | ﹤0.01% |
90,700
-7,106
| -7% | -$33.3K |
|
3233
Kaiser Aluminum
KALU
$2.61B
| $471K | ﹤0.01% |
5,000
-20,600
| -80% | -$1.99M |
|
3234
Madrigal Pharmaceuticals
MDGL
$10.8B
| $471K | ﹤0.01% |
4,800
+2,400
| +100% | +$202K |
|
3235
Invesco BuyBack Achievers ETF
PKW
$1.72B
| $470K | ﹤0.01% |
5,200
-4,400
| -46% | -$404K |
|
3236
SB Financial Group
SBFG
$164M
| $470K | ﹤0.01% |
23,625
+41
| +0.2% | +$796 |
|
3237
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
| $469K | ﹤0.01% |
9,100
-2,215
| -20% | -$118K |
|
|
FNCB
3238
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $469K | ﹤0.01% |
49,500
-6,491
| -12% | -$60.7K |
|
|
BNSO
3239
DELISTED
Bonso Electronic International
BNSO
| $469K | ﹤0.01% |
146,000
-3,300
| -2% | -$12.9K |
|
3240
Perella Weinberg Partners
PWP
$1.29B
| $467K | ﹤0.01% |
49,400
-244
| -0.5% | -$2.6K |
|
3241
DoubleVerify
DV
$1.73B
| $466K | ﹤0.01% |
18,500
-78,800
| -81% | -$2.05M |
|
3242
ESS Tech
GWH
$22M
| $466K | ﹤0.01% |
5,573
+4,886
| +711% | +$436K |
|
3243
Bank First Corp
BFC
$1.69B
| $465K | ﹤0.01% |
+6,464
| New | +$460K |
|
|
SWKH
3244
DELISTED
SWK Holdings
SWKH
| $464K | ﹤0.01% |
34,705
-14,892
| -30% | -$221K |
|
|
SIEN
3245
DELISTED
Sientra, Inc.
SIEN
| $463K | ﹤0.01% |
20,877
+16,002
| +328% | +$438K |
|
3246
WisdomTree US MidCap Dividend Fund
DON
$4.03B
| $462K | ﹤0.01% |
10,400
+1,500
| +17% | +$65.6K |
|
3247
Janus Henderson AAA CLO ETF
JAAA
$29B
| $462K | ﹤0.01% |
+9,200
| New | +$463K |
|
3248
Protagonist Therapeutics
PTGX
$8.79B
| $461K | ﹤0.01% |
+19,467
| New | +$548K |
|
3249
iShares MSCI Turkey ETF
TUR
$200M
| $460K | ﹤0.01% |
+22,200
| New | +$437K |
|
|
SSY
3250
DELISTED
SunLink Health Systems
SSY
| $458K | ﹤0.01% |
313,928
-17,356
| -5% | -$24.4K |
|
Similar funds
Renaissance Technologies's Q1 2022 Portfolio in Review
As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
- Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
- Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.